UAM | UAM_Biblioteca | Unified search engine | Scientific Production Portal | UAM Research Data Repository
Biblos-e Archivo
    • español
    • English
  • English 
    • español
    • English
  • Log in
JavaScript is disabled for your browser. Some features of this site may not work without it.

Search Biblos-e Archivo

Advanced Search

Browse

All of Biblos-e ArchivoCommunities & CollectionsBy Issue DateAuthorsTitlesSubjectsFacultiesThis CollectionBy Issue DateAuthorsTitlesSubjectsFaculties

My Account

Log inRegister

Statistics

View Usage Statistics

Help

Information about Biblos-e ArchivoI want to submit my workFrequently Asked Questions

UAM_Biblioteca

View Item 
  •   Biblos-e Archivo
  • 1 - Producción científica en acceso abierto de la UAM
  • Producción científica en acceso abierto de la UAM
  • View Item
  •   Biblos-e Archivo
  • 1 - Producción científica en acceso abierto de la UAM
  • Producción científica en acceso abierto de la UAM
  • View Item

MEK inhibition enhances the response to tyrosine kinase inhibitors in acute myeloid leukemia

Author
Morales, María Luz; Arenas, Alicia; Ortiz-Ruiz, Alejandra; Leivas, Alejandra; Rapado, Inmaculada; Ortiz-Ruiz, Alba; Castro, Nerea; Zagorac, Ivana; Quintela Fandiño, Miguel Ángeluntranslated; Gómez López, Gonzalountranslated; Gallardo, Miguel; Ayala, Rosa; Linares, María; Martínez-López, Joaquín
Entity
UAM. Departamento de Bioquímica
Publisher
Nature Research
Date
2019-12-09
Citation
10.1038/s41598-019-54901-9
Scientific Reports volume 9 (2019): 18630
 
 
 
ISSN
2045-2322
DOI
10.1038/s41598-019-54901-9
Funded by
This work was supported by the Instituto de Salud Carlos III (PI13/02378 and PI16/01530) and the CRIS foundation. M.L. had a postdoctoral fellowship from the Spanish Ministry of Economy and Competitiveness (FPDI-2013-016409) and holds a grant from the Spanish Society of Hematology and Hemotherapy
Project
Gobierno de España. PI13/02378; Gobierno de España. PI16/01530
Editor's Version
https://doi.org/10.1038/s41598-019-54901-9
Subjects
Cancer therapeutic resistence; Targeted therapies; Trasnational research; Medicina
URI
http://hdl.handle.net/10486/692178
Rights
© 2019 The Authors

Licencia Creative Commons
Esta obra está bajo una Licencia Creative Commons Atribución 4.0 Internacional.

Abstract

FMS-like tyrosine kinase 3 (FLT3) is a key driver of acute myeloid leukemia (AML). Several tyrosine kinase inhibitors (TKIs) targeting FLT3 have been evaluated clinically, but their effects are limited when used in monotherapy due to the emergence of drug-resistance. Thus, a better understanding of drug-resistance pathways could be a good strategy to explore and evaluate new combinational therapies for AML. Here, we used phosphoproteomics to identify differentially-phosphorylated proteins in patients with AML and TKI resistance. We then studied resistance mechanisms in vitro and evaluated the efficacy and safety of rational combinational therapy in vitro, ex vivo and in vivo in mice. Proteomic and immunohistochemical studies showed the sustained activation of ERK1/2 in bone marrow samples of patients with AML after developing resistance to FLT3 inhibitors, which was identified as a common resistance pathway. We examined the concomitant inhibition of MEK-ERK1/2 and FLT3 as a strategy to overcome drug-resistance, finding that the MEK inhibitor trametinib remained potent in TKI-resistant cells and exerted strong synergy when combined with the TKI midostaurin in cells with mutated and wild-type FLT3. Importantly, this combination was not toxic to CD34+ cells from healthy donors, but produced survival improvements in vivo when compared with single therapy groups. Thus, our data point to trametinib plus midostaurin as a potentially beneficial therapy in patients with AML.
Show full item record

Files in this item

Thumbnail
Name
MEK_morales_SR_2019.pdf
Size
2.015Mb
Format
PDF

Refworks Export

Google™ Scholar:Morales, María Luz - Arenas, Alicia - Ortiz-Ruiz, Alejandra - Leivas, Alejandra - Rapado, Inmaculada - Ortiz-Ruiz, Alba - Castro, Nerea - Zagorac, Ivana - Quintela Fandiño, Miguel Ángel - Gómez López, Gonzalo - Gallardo, Miguel - Ayala, Rosa - Linares, María - Martínez-López, Joaquín

This item appears in the following Collection(s)

  • Producción científica en acceso abierto de la UAM [18125]

Related items

Showing items related by title, author, creator and subject.

  • A novel deep targeted sequencing method for minimal residual disease monitoring in acute myeloid leukemia 

    Onecha, Esther; Linares, María; Rapado, Inmaculada; Ruiz-Heredia, Yanira; Martínez-Sánchez, Pilar; Cedena, Teresa; Pratcorona, Marta; Pçerez Oteyza, Jaime; Herrera, Pilar; Barragan, Eva; Montesinos, Pau; García Vela, José Antonio; Magro, Elena; Anguita, Eduardo; Figuera Álvarez, ÁngelaAutoridad UAM; Riaza, Rosalía; Martínez-Barranco, Pilar; Sánchez-Vega, Beatriz; Nomdedeu, Josep; Gallardo, Miguel; Martínez-López, Joaquín; Ayala, Rosa
    2019-01-31
  • GMP-compliant manufacturing of NKG2D CAR Memory T cells using CliniMACS prodigy 

    Fernández, Lucía; Fernández, Adrián; Mirones, Isabel; Escudero, Adela; Cardoso, Leila; Vela, María; Lanzarot, Diego; Paz, Raquel de; Leivas, Alejandra; Gallardo, Miguel; Marcos, Antonio; Romero, Ana Belén; Martínez-López, Joaquín; Pérez Martínez, AntonioAutoridad UAM
    2019-10-10
  • Metabolic plasticity is an essential requirement of acquired tyrosine kinase inhibitor resistance in chronic myeloid leukemia 

    Contreras Mostazo, Miriam G.; Kurrle, Nina; Casado, Marta; Fuhrmann, Dominik; Alshamleh, Islam; Häupl, Björn; Martín-Sanz, Paloma; Brüne, Bernhard; Serve, Hubert; Schwalbe, Harald; Schnütgen, Frank; Marin, Silvia; Cascante, Marta
    2020-11-01
All the documents from Biblos-e Archivo are protected by copyrights. Some rights reserved.
Universidad Autónoma de Madrid. Biblioteca
Contact Us | Send Feedback
We are onFacebookCanal BiblosYouTubeTwitterPinterestWhatsappInstagram

Declaración de accesibilidad

 

 

All the documents from Biblos-e Archivo are protected by copyrights. Some rights reserved.
Universidad Autónoma de Madrid. Biblioteca
Contact Us | Send Feedback
We are onFacebookCanal BiblosYouTubeTwitterPinterestWhatsappInstagram

Declaración de accesibilidad